Romidepsin is a novel agent in a new class of anti-cancer drugs, known as histone deacetylase inhibitors or  HDACi's. Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide.

1. Karen M. VanderMolen, William McCulloch, Cedric J. Pearce, et al. Romidepsin (Istodax?, NSC 630176, FR901228, FK228, Depsipeptide): A Natural Product Recently Approved for Cutaneous T-cell Lymphoma . J Antibiot (Tokyo). 2011 August; 64(8): 525-531.

2. CE Tiffon, JE Adams, L van der Fits , et al. The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells .Br J Pharmacol. 2011 April; 162(7): 1590-1602.